PHA Classroom banner

PHA Classroom has moved! Visit

>>Back to All Recordings

>>Back to About PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
Guinea Pig or Hero – The Journey through Clinical Trials

June 23, 2012

Clinical trials in pulmonary arterial hypertension have led to the FDA approval of nine medicines over the past 17 years! This is great for the community as a whole, but what is it like for an individual patient to participate in a research trial? Experienced researchers will discuss the benefits and potential risks of clinical trials.

Presenter Information

Karen Fagan, MD, University of South Alabama, Mobile, Ala. (Chair); Serpil Erzurum, MD, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio; Jeremy Feldman, MD, Arizona Pulmonary Specialists, LTD, Phoenix, Ariz.; Steven Kawut, MD, Pereleman School of Medicine, University of Pennsylvania, Philadelphia, Pa.








Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.